Drug companies benefit from FDA regulation because compliance costs are a fixed cost startups cannot bear, excluding rivals; in Bruce Yandle's bootleggers-and-Baptists terms, companies are the bootleggers and safety advocates are the Baptists, producing a strong political coalition for an overly zealous FDA.

causalpending

Speaker

Russ Roberts

Evidence Quote

“The cynical argument is that the drug companies benefit from FDA regulation”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...